Biological Target
Glucagon-like peptide-1 receptor, Glucose-dependent insulinotropic polypeptide receptor
Biological Target
Glucagon-like peptide-1 receptor, Glucose-dependent insulinotropic polypeptide receptor Description
The Glucagon-like peptide-1 receptor (GLP-1R) and Glucose-dependent insulinotropic polypeptide receptor (GIPR) are class B G protein-coupled receptors expressed on various cell types, including pancreatic beta-cells, enteroendocrine cells, and neurons. Upon activation by their respective endogenous incretin hormones, GLP-1 and GIP, these receptors stimulate glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and promote satiety. These actions collectively contribute to the regulation of glucose homeostasis and energy balance in the body.
Medications Targeting Glucagon-like peptide-1 receptor, Glucose-dependent insulinotropic polypeptide receptor
No approved therapeutics or investigational compounds are currently cataloged for this target in our database.